Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China
· Delayed Price · Currency is CNY 4.200
+0.110 (2.69%)
Apr 29, 2026, 3:14 PM CST
SHE:300267 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 976.83 | 897.4 | 698.54 | 744.35 | 764.67 | 761.56 | Upgrade
|
| Trading Asset Securities | 90 | 90 | 120 | 0.12 | 114.12 | - | Upgrade
|
| Cash & Short-Term Investments | 1,067 | 987.4 | 818.54 | 744.47 | 878.79 | 761.56 | Upgrade
|
| Cash Growth | 51.10% | 20.63% | 9.95% | -15.28% | 15.39% | -40.90% | Upgrade
|
| Accounts Receivable | 202.12 | 202.39 | 198.3 | 177.8 | 204.48 | 274.36 | Upgrade
|
| Other Receivables | 3.53 | 3.62 | 4.46 | 18.17 | 27.81 | 13.57 | Upgrade
|
| Receivables | 205.65 | 206.02 | 202.77 | 195.97 | 232.29 | 287.93 | Upgrade
|
| Inventory | 523.93 | 512 | 600.78 | 691.6 | 821.34 | 714.77 | Upgrade
|
| Prepaid Expenses | - | - | - | 1.39 | - | - | Upgrade
|
| Other Current Assets | 122.73 | 83.15 | 95 | 97.58 | 158.78 | 182.1 | Upgrade
|
| Total Current Assets | 1,919 | 1,789 | 1,717 | 1,731 | 2,091 | 1,946 | Upgrade
|
| Property, Plant & Equipment | 2,384 | 2,425 | 2,716 | 2,917 | 2,857 | 2,604 | Upgrade
|
| Long-Term Investments | 99.75 | 99.8 | 121.74 | 170.23 | 188.97 | 196.16 | Upgrade
|
| Goodwill | 2 | 2 | 2 | 2 | 10.01 | 10.01 | Upgrade
|
| Other Intangible Assets | 312.64 | 317.12 | 363.56 | 378.03 | 406.14 | 431.45 | Upgrade
|
| Long-Term Deferred Tax Assets | 119.8 | 120.4 | 150.55 | 152.14 | 168.92 | 118.34 | Upgrade
|
| Long-Term Deferred Charges | 8.89 | 9.56 | 10.66 | 12.08 | 19.5 | 16.51 | Upgrade
|
| Other Long-Term Assets | 112.91 | 98.25 | 117.78 | 116.25 | 114.6 | 108.75 | Upgrade
|
| Total Assets | 4,959 | 4,861 | 5,200 | 5,479 | 5,856 | 5,432 | Upgrade
|
| Accounts Payable | 113.47 | 121.07 | 114.66 | 122.3 | 198.7 | 137.87 | Upgrade
|
| Accrued Expenses | 12.41 | 25.01 | 26.09 | 31.22 | 23.38 | 33.79 | Upgrade
|
| Short-Term Debt | 684.51 | 551.38 | 488.2 | 341.89 | 396.64 | 246 | Upgrade
|
| Current Portion of Long-Term Debt | 4.82 | 8.79 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 3.69 | 2.16 | 4.11 | 3.88 | Upgrade
|
| Current Income Taxes Payable | 3.14 | 8.75 | 0.17 | 0.99 | 0.97 | 0.74 | Upgrade
|
| Current Unearned Revenue | 39.54 | 26.17 | 29.82 | 47.01 | 51.31 | 37.35 | Upgrade
|
| Other Current Liabilities | 59.01 | 61.56 | 42.71 | 57.73 | 50.33 | 39.3 | Upgrade
|
| Total Current Liabilities | 916.91 | 802.73 | 705.34 | 603.3 | 725.43 | 498.93 | Upgrade
|
| Long-Term Leases | 27.72 | 27.86 | 17.38 | 1.17 | 2.58 | 2.15 | Upgrade
|
| Long-Term Unearned Revenue | 9.2 | 10.06 | 14.93 | 18.39 | 23.15 | 27.91 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 46.35 | 46.32 | 46.9 | 46.2 | 53.41 | 29.29 | Upgrade
|
| Other Long-Term Liabilities | - | - | 12.99 | - | - | - | Upgrade
|
| Total Liabilities | 1,000 | 886.97 | 797.54 | 669.05 | 804.57 | 558.28 | Upgrade
|
| Common Stock | 2,063 | 2,063 | 2,063 | 2,063 | 2,063 | 2,063 | Upgrade
|
| Additional Paid-In Capital | 1,019 | 1,019 | 1,019 | 1,019 | 1,005 | 998.96 | Upgrade
|
| Retained Earnings | 937.38 | 924.27 | 1,304 | 1,677 | 1,935 | 1,889 | Upgrade
|
| Comprehensive Income & Other | 2.73 | 27.95 | 61.27 | 76.52 | 48.34 | -99.15 | Upgrade
|
| Total Common Equity | 4,022 | 4,034 | 4,447 | 4,836 | 5,051 | 4,851 | Upgrade
|
| Minority Interest | -62.86 | -60.24 | -45.23 | -26.03 | 0.27 | 22.49 | Upgrade
|
| Shareholders' Equity | 3,959 | 3,974 | 4,402 | 4,810 | 5,051 | 4,874 | Upgrade
|
| Total Liabilities & Equity | 4,959 | 4,861 | 5,200 | 5,479 | 5,856 | 5,432 | Upgrade
|
| Total Debt | 717.05 | 588.03 | 509.27 | 345.21 | 403.33 | 252.04 | Upgrade
|
| Net Cash (Debt) | 349.79 | 399.38 | 309.27 | 399.25 | 475.46 | 509.53 | Upgrade
|
| Net Cash Growth | 23.16% | 29.13% | -22.54% | -16.03% | -6.69% | -38.28% | Upgrade
|
| Net Cash Per Share | 0.17 | 0.19 | 0.15 | 0.19 | 0.23 | 0.25 | Upgrade
|
| Filing Date Shares Outstanding | 2,048 | 2,069 | 2,063 | 2,063 | 2,063 | 2,063 | Upgrade
|
| Total Common Shares Outstanding | 2,048 | 2,069 | 2,063 | 2,063 | 2,063 | 2,063 | Upgrade
|
| Working Capital | 1,002 | 985.84 | 1,012 | 1,128 | 1,366 | 1,447 | Upgrade
|
| Book Value Per Share | 1.96 | 1.95 | 2.16 | 2.34 | 2.45 | 2.35 | Upgrade
|
| Tangible Book Value | 3,708 | 3,715 | 4,082 | 4,456 | 4,635 | 4,410 | Upgrade
|
| Tangible Book Value Per Share | 1.81 | 1.80 | 1.98 | 2.16 | 2.25 | 2.14 | Upgrade
|
| Buildings | - | - | 1,933 | 1,990 | 1,926 | 1,740 | Upgrade
|
| Machinery | - | - | 1,914 | 1,878 | 1,896 | 1,224 | Upgrade
|
| Construction In Progress | - | - | 174.58 | 220.89 | 52.92 | 506.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.